Figure 2.
Measurement of exosomal and free Hsp70 in the peripheral blood of healthy volunteers vs. NSCLC patients as determined by the compHsp70 ELISA. The Hsp70 levels were compared in healthy controls (n = 42) vs. NSCLC patients in different UICC stages (n = 113) (A) and in healthy controls (n = 42) vs. NSCLC patients in UICC stages I (n = 6), IIIA (n = 32), IIIB (n = 33), and IV (n = 42) (B). Statistically significant differences were ** p < 0.01 and **** p < 0.0001.
